Methodological issues associated with clinical trials in epilepsy-Reference-Cited by-同舟云学术

Methodological issues associated with clinical trials in epilepsy

Published:2017-07-25 Issue:10 Volume:10 Page:1103-1108
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Ferlazzo Edoardo¹²,Sueri Chiara¹,Gasparini Sara¹²,Russo Emilio³,Cianci Vittoria¹,Ascoli Michele¹²,De Sarro Giovambattista³,Aguglia Umberto¹²

Affiliation:

1. Regional Epilepsy Centre, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy

2. Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy

3. Department of Science of Health, Magna Graecia University, Catanzaro, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2017.1356720

Reference60 articles.

1. What clinical trial designs have been used to test antiepileptic drugs and do we need to change them?

2. Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions

3. Patterns of treatment response in newly diagnosed epilepsy

4. U.S. National Library of Medicine. 8600 Rockville Pike, Bethesda, MD: 20894 National Institutes of Health, Health & Human Services. cited 2017 Jun 28. Available from: http://www.clinicaltrials.gov

5. Trial Design: How Do We Figure Out if an AED Works

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scavenger Receptor Class B Type I Modulates Epileptic Seizures and Receptor α2δ-1 Expression;Neurochemical Research;2024-07-17

2. Induced Pluripotent Stem Cell-Based Systems for Personalising Epilepsy Treatment: Research Ethics Challenges and New Insights for the Ethics of Personalised Medicine;AJOB Neuroscience;2021-07-29

3. Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review;CNS Drugs;2020-07-23

4. Testing rimegepant for migraine—time to revise the trial design?;The Lancet;2020-06

5. Testing rimegepant for migraine—time to revise the trial design? – Authors' reply;The Lancet;2020-06